MTNB 8-K 2026-09-28

Matinas BioPharma Holdings, Inc. (MTNB) 8-K dated 2026-09-28 — accession 0001493152-26-044451. This URL is the filing, not the MTNB hub.

Matinas BioPharma Holdings, Inc. (MTNB) is a biotechnology company listed on US.

Matinas BioPharma Holdings, Inc. filed a 8-K on 2026-09-28. Accession 0001493152-26-044451.

Cached items: 3.03, 5.03, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported MTNB revenue for 2023-12-31 was $1.1M. Net income was -$22.9M. MTNB currently screens at market cap $5.6M.

Not investment advice. The MTNB SEC hub lists recent forms. The stock page is the research view.